Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Sensorimotor gating and dopamine function in postpartum rats.

Byrnes EM, Bridges RS, Scanlan VF, Babb JA, Byrnes JJ.

Neuropsychopharmacology. 2007 May;32(5):1021-31. Epub 2006 Oct 18.

2.

Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.

de Bruin NM, Ellenbroek BA, van Luijtelaar EL, Cools AR, Stevens KE.

Neuroscience. 2001;105(1):169-80.

PMID:
11483310
3.

Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice.

Mohr D, Pilz PK, Plappert CF, Fendt M.

Neuroreport. 2007 Sep 17;18(14):1493-7.

PMID:
17712281
5.
6.

Reduced G(i) and G(o) protein function in the rat nucleus accumbens attenuates sensorimotor gating deficits.

Culm KE, Lim AM, Onton JA, Hammer RP Jr.

Brain Res. 2003 Aug 22;982(1):12-8.

PMID:
12915235
7.

Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats.

Wan FJ, Swerdlow NR.

Psychopharmacology (Berl). 1993;113(1):103-9.

PMID:
7862814
9.

Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating.

Alsene KM, Rajbhandari AK, Ramaker MJ, Bakshi VP.

Neuropsychopharmacology. 2011 Apr;36(5):1003-14. doi: 10.1038/npp.2010.238. Epub 2011 Jan 19.

10.

The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.

Frau R, Mosher LJ, Bini V, Pillolla G, Pes R, Saba P, Fanni S, Devoto P, Bortolato M.

Psychoneuroendocrinology. 2016 Jan;63:59-67. doi: 10.1016/j.psyneuen.2015.09.014. Epub 2015 Sep 24.

11.

Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.

Weber M, Chang WL, Breier M, Ko D, Swerdlow NR.

Behav Pharmacol. 2008 Dec;19(8):786-95. doi: 10.1097/FBP.0b013e32831c3b2b.

12.

Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.

Ralph-Williams RJ, Lehmann-Masten V, Geyer MA.

Neuropsychopharmacology. 2003 Jan;28(1):108-18.

13.

Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow.

Koeltzow TE, Austin JD, Vezina P.

Neuropharmacology. 2003 Jan;44(1):102-10.

PMID:
12559127
14.

Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity.

Perna MK, Brown RW.

Behav Brain Res. 2013 Apr 1;242:102-9. doi: 10.1016/j.bbr.2012.12.037. Epub 2013 Jan 3.

PMID:
23291224
16.

cAMP response element binding protein phosphorylation in nucleus accumbens underlies sustained recovery of sensorimotor gating following repeated D₂-like receptor agonist treatment in rats.

Berger AK, Green T, Siegel SJ, Nestler EJ, Hammer RP Jr.

Biol Psychiatry. 2011 Feb 1;69(3):288-94. doi: 10.1016/j.biopsych.2010.08.032. Epub 2010 Oct 30.

17.

Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.

Culver KE, Szechtman H, Levant B.

Eur J Pharmacol. 2008 Sep 11;592(1-3):67-72. doi: 10.1016/j.ejphar.2008.06.101. Epub 2008 Jul 4.

18.

Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats.

Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP.

Neuropsychopharmacology. 2006 Mar;31(3):506-15.

19.
20.

A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.

Peng RY, Mansbach RS, Braff DL, Geyer MA.

Neuropsychopharmacology. 1990 Jun;3(3):211-8.

PMID:
2141986

Supplemental Content

Support Center